eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
vol. 72
Letter to the Editor

Endometrial adenocarcinoma with gastrointestinal differentiation – a newly described entity, with morphologic diversity

Simona Stolnicu
Cristian Podoleanu
Ildiko Orban
Rozsnyai Francisc

Department of Pathology, University of Medicine, Pharmacy, Science and Technology of Targu Mures, Romania
Department of Cardiology, University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, Romania
Department of Pathology, Emergency Hospital, Targu Mures, Romania
Department of Gynecology and Obstetrics, University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, Romania
Pol J Pathol 2021; 72 (1): 84-86
Online publish date: 2021/05/31
Article file
- 09-PJP-02057.pdf  [2.47 MB]
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Dear Sir,
A 64-year-old patient was admitted to the Gynecology Department due to vaginal bleeding. Ultrasound examination revealed a polypoid uterine lesion of 6 mm diameter and a Pipelle biopsy was recommended. At microscopic examination, atypical glands and villoglandular structures were lined by a mucinous columnar epithelium, being compatible with mucinous adenocarcinoma. Total hysterectomy with bilateral salpingo-oophorectomy was performed and at macroscopic examination, the uterine cavity was filled with a polypoid tumor of 7 mm diameter, surrounded by diffusely thickened endometrial mucosa. Microscopic examination revealed variable architecture of glands and papillae, involving the polypoid tumor as well as in the adjacent endometrium. Most of these structures (80%) were lined by a mucinous columnar epithelium, with abundant clear or eosinophilic cytoplasm, distinct cellular membranes and basally located nuclei, with mild to moderate atypia. Focal intestinal differentiation in the form of goblet cells as well as small non-villous papillae were also identified. Conspicuous neutrophilic infiltrate was present among the neoplastic glands and surrounding stroma while lymphovascular invasion was not present. However, 20% of the tumor glands were lined with stratified atypical cells, with little cytoplasm, suggesting endometrioid differentiation. Immunohistochemical examination showed a similar profile, with tumor cells being positive for MUC6 and p16 as well as for MSH2, MSH6, MLH1, and PMS2, while ER, PR, and CDX2 were only focally positive and p53 staining was of wild type (Fig. 1). The morphology and immunohistochemical profile are suggestive for an infiltrating endometrial adenocarcinoma of mucinous gastrointestinal type, FIGO grade 2 limited to the endometrium (FIGO stage IA). Isolated case reports of primary gastric or gastrointestinal type of endometrial adenocarcinoma have been published to date [1, 2, 3, 4, 5, 6]. More recently, Wong et al. published the largest series of 4 cases, with detailed histologic and immunohistochemical analysis and clearly defined diagnostic criteria [7]. Consequently, the latest WHO 2020 classification incorporated gastrointestinal mucinous adenocarcinoma of endometrium as a distinct entity [8]. The rarity of the tumor may also be due to the fact that in the absence of a specific designation in the previous WHO (2014) classification, this neoplasm was most likely classified as endometrioid adenocarcinoma with mucinous differentiation. Among the well-defined morphologic criteria, gastrointestinal mucinous adenocarcinoma of endometrium must not show a typical endometrioid component. In the present case, the morphology was admixed, with areas showing gastric differentiation (MUC6-positive) and intestinal differentiation (CDX2-positive) as well as an endometrioid-like component and areas presenting with small non-villous papillae. However, the endometrioid-like component not only did not show classic squamous metaplasia, but was also MUC6-positive, while the positivity for ER and PR was only focal. Consequently, the recognition of gastric/gastrointestinal differentiation in endometrial carcinomas is best accomplished using both morphology and immunohistochemistry rather than either alone. When the morphology overlaps with low-grade endometrioid adenocarcinoma, the absence of squamous elements or of significant expression of hormone receptors would support the diagnosis of gastrointestinal mucinous adenocarcinoma together with the morphology. Of interest, we have previously reported that besides all human papillomavirus (HPV)-associated mucinous endocervical adenocarcinomas, one third of gastric type HPV-independent endocervical adenocarcinomas may be block-like p16-positive [9]. Also, Wong et al. described block-like p16-positivity in one of 4 cases of gastric adenocarcinoma of endometrium. This is an important point to consider when dealing with curettage material, and the differential diagnosis is between gastric type adenocarcinoma with endometrial or endocervical origin versus mucinous HPV-associated endocervical adenocarcinoma, since gastric type endometrial adenocarcinoma can be block-like positive for p16, as in the present case [7, 9, 10]. The importance of differentiating between gastrointestinal and endometrioid type resides in the prognosis and management. Similar to gastric type adenocarcinoma of the cervix and vagina, endometrial adenocarcinomas with gastric differentiation in general exhibit aggressive clinical behavior. In the series by Wong, among the 4 cases, visceral metastases were present in 3, with 2 patients dead of the disease and the other alive with progressive disease [7]. Similarly, both cases reported by Hino et al. were advanced at diagnosis and the patients died from the disease, one with lung metastases and the other with peritoneal carcinomatosis [4]. This illustrates the importance of separating these neoplasms from conventional Müllerian type mucinous or endometrioid adenocarcinomas, and they should probably be managed as high-grade neoplasms.

The authors declare no conflict of interest.


1. Zheng W, Yang GC, Godwin TA, et al. Mucinous adenocarcinoma of the endometrium with intestinal differentiation: a case report. Hum Pathol 1995; 26: 1385-1388.
2. Abiko K, Baba T, Ogawa M, et al. Minimal deviation mucinous adenocarcinoma (“adenoma malignum”) of the uterine corpus. Pathol Int 2010; 60: 42-47.
3. Buell-Gutbrod R, Sung CJ, Lawrence WD, et al. Endometrioid adenocarcinoma with simultaneous endocervical and intestinal-type mucinous differentiation: report of a rare phenomenon and the immunohistochemical profile. Diagn Pathol 2013; 8: 128.
4. Hino M, Yamaguchi K, Abiko K, et al. Magnetic resonance imaging findings and prognosis of gastric-type mucinous adenocarcinoma (minimal deviation adenocarcinoma or adenoma malignum) of the uterine corpus: two case reports. Mol Clin Oncol 2016; 4: 699-704.
5. Rubio A, Schuldt M, Guarch R, et al. Pseudomyxoma-type invasion in gastrointestinal adenocarcinomas of endometrium and cervix: a report of 2 cases. Int J Gynecol Pathol 2016; 35: 118-122.
6. McCarthy WA, Makhijani R, Miller K, et al. Gastric-type endometrial adenocarcinoma: report of two cases in patients from the United States. Int J Surg Pathol 2018; 26: 377-381.
7. Wong RWC, Ralte A, Grondin K, et al. Endometrial gastric (gastrointestinal)-type mucinous lesions. Report of a series illustrating the spectrum of benign and malignant lesions. Am
8. J Surg Pathol 2020; 44: 406-419.
9. WHO Classification of Tumors: Female Genital Tumors, 5th edition, IARC, 2020.
10. Stolnicu S, Barsan I, Hoang L, et al. Diagnostic algorithmic proposal based on comprehensive immunohistochemical evaluation of 297 invasive endocervical adenocarcinomas. Am J Surg
11. Pathol 2018; 42: 989-1000.
12. Stolnicu S, Barsan I, Hoang L, et al. International endocervical adenocarcinoma criteria and classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix. Am J Surg Pathol 2018; 42: 214-226.
Copyright: © 2021 Polish Association of Pathologists and the Polish Branch of the International Academy of Pathology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.